1. Introduction & Epidemiological Framework
Treatment-resistant depression (TRD) represents one of the most significant diagnostic and therapeutic challenges in contemporary neuropsychiatry. When major depressive disorder fails to achieve remission following standard sequential pharmacotherapeutic trials, targeted neuromodulatory modalities are clinically indicated.
In outpatient psychiatric practice, specialized neuromodulatory interventions provided by clinical transcranial magnetic stimulation therapy demonstrate robust remission rates and sustained functional restoration across refractory cohorts.
2. Neurobiological Mechanisms of rTMS
High-frequency repetitive transcranial magnetic stimulation (HF-rTMS) applied to the left dorsolateral prefrontal cortex (DLPFC) induces localized neuronal depolarization that propagates trans-synaptically along cortico-striatal-thalamo-cortical loops.